GNRH ANTAGONISTS MODIFIED AT POSITIONS 5 AND 6 Russian patent published in 2003 - IPC

Abstract RU 2199549 C2

FIELD: organic chemistry, peptides, pharmacy. SUBSTANCE: invention relates to peptide-antagonists of GnRH of the formula: X-D-Nal-(A)D-Phe-D-Pal-Ser-Xaa5-Xaa6-Leu-Xaa8-Pro-Xaa10 and their pharmaceutically acceptable salts where X means acyl group with more 7 carbon atoms; A means 4-Cl or Br; Xaa5 means Aph(Q1) or Amf(Q1) where Q1 means Q or or (D- or L-Hor), (D- or L-Imz) where Q means and where R means H or lower alkyl; Xaa6 means D-Aph(Q2), D-Amf(Q2), D-Cit or D-Pal where Q2 means Ac or Q1; Xaa8 means Lys(ipr); and Xaa10 means D-Ala-NH2, D-Ala-ol, Ala-ol, NHCH2CH3, Gly-NH2 or Ala-NH2 under condition that if Xaa5 involves Q then Xaa6 means Q also. Invention relates also to pharmaceutical composition for inhibition of gonadotropin secretion in mammals comprising effective antagonist of GnRH as active component. Invention relates also to method of inhibition of gonadotropin secretion in mammals and to compounds of the formula: X1-D-Nal-(A)D-Phe-D-Pal-Ser(X2)-Xaa5-Xaa6-Leu-Lyx(ipr)(X4)-Pro-X5 where X1 is α-amino-protective group; A is 4-Cl or 4-Br; X2 is H or hydroxy-protective group; Xaa5 means Aph(Q1) or Amf(Q1) where Q1 means structures (I) and (II) or carbamoyl or methyl-carbamoyl; Xaa6 means D-Amf(Q2), D-Amf(Q2) or D-Pal where Q2 is Ac; X4 means amino-protective group sensitive to acid effect; X5 means D-Ala-, Gly-, Ala-[polymeric carrier] , N(Et)-[polymeric carrier], D-Ala, Gly or Ala amide; or ethylamide as intermediate compound for synthesis of peptide-antagonist of GnRH receptors. EFFECT: valuable medicinal properties of compounds. 16 cl, 8 ex

Similar patents RU2199549C2

Title Year Author Number
METHOD FOR PRODUCTION OF DEGARELIX AND INTERMEDIATE COMPOUNDS THEREOF 2011
  • Rasmussen Jon Kholbek
  • Fomsgord Jens
  • Khansen Stefan
  • Rasmussen Palle Khedengran
  • Vaks Volfgang Oliver
RU2602042C2
METHOD OF OBTAINING DEGARELIX 2010
  • Zhang Haixiang
  • Fomsgaard Jens
  • Staerkaer Gunnar
RU2515555C2
SYNTHETIC INTERMEDIATES FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) ANTAGONISTS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR PRODUCTION OF LHRH ANTAGONISTS 2002
  • Rasmussen Jon Kh.
  • Rasmussen Palle Kh.
  • Vaks Vol'Fgang O.
  • Khansen Stefan
  • Fomsgor Ens
RU2307125C2
MANUFACTURE OF DEGARELIX 2013
  • Schwach Gregoire
  • Nilsson Anders
  • Gottschalk Boeving Tine Elisabeth
  • Rasmussen Jon Holbech
  • Mornstam Birgitta
  • Tsirk Anders
  • Annby Ulf
  • Fomsgaard Jens
RU2657444C2
COMPOSITION FOR TREATING PROSTATE CANCER 2010
  • Olesen Tine Kold
  • Cantor Per
  • Erichsen Lars
RU2536245C2
PEPTIDE COMPOSITIONS AND METHODS FOR PRODUCTION THEREOF 2009
  • Leonard Tomas U.
RU2517135C2
LHRH ANTAGONISTS, THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND ITS PREPARING, METHOD FOR TREATMENT OF TUMOR AND INFERTILITY IN MAMMALS 2001
  • Bekers Tomas
  • Bernd Mikhaehl'
  • Gjunter Ehkkhard
  • Kucher Berngard
  • Rejssmann Tomas
  • Romejs Peter
RU2248982C9
DECAPEPTIDE SHOWING ANTITUMOR ACTIVITY 1993
  • Vlasov G.P.
  • Burov S.V.
  • Semko T.V.
RU2084458C1
COMPOSITION WITH CONTROLLED-RELEASE COMPRISING GNRH-II 1999
  • Kvi Stiv
  • Akinsan'Ja Karen
  • Khejvard Amanda
RU2233170C2
ANTAGONIST OF LH-RELEASING FACTOR (LHRH), COMPLEX, METHOD OF CHEMICAL CASTRATION AND/OR TREATMENT OF GONADOTROPIN- -DEPENDENT DISORDERS 1994
  • Gregori Dzhon Rassell-Dzhons
RU2130464C1

RU 2 199 549 C2

Authors

Sempl Gram

Zhiang Guangcheng

Dates

2003-02-27Published

1998-04-13Filed